Award notice Supplies
Accord-cadre ayant pour objet la fourniture d'antibiotiques et d'antiviraux per os
Notice published in French. The AI analysis summarises it for you in your language.
- Public buyer
- Centrale de Négociation pour les Achats Hospitaliers
Erpent - Place of performance
- 5101 Erpent
not published: buyer's address - Planned end of contract
- 18 April 2028
likely re-tender around October 2027 - Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 2 January 2025
- Notice language
- French
What is the authority looking for?
Supplies · Produits pharmaceutiques, vaccins
Cet accord-cadre a pour objet la fourniture d'antibiotiques et d'antiviraux per os
Where and when?
5101 Erpent (buyer's address)
Deadline not published in the notice
Site visit and deadline for questions: stated in the specifications, not in the notice.
What budget?
Amount not published in the notice. The AI analysis and comparable tenders give an order of magnitude.
Why is this tender relevant to me?
Create your free account : we compare every tender with your trade and your area.
Can I consider bidding?
The AI analysis extracts the participation conditions, the contractor approval and the required documents. See the analysis and the verdict for your company
Nothing is assumed: what the notice does not say is marked "to check".
What do I need to do?
1. Read the analysis · 2. Check that you meet the conditions · 3. Prepare the response · 4. Submit on the official platform before the deadline.
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Cet accord-cadre a pour objet la fourniture d'antibiotiques et d'antiviraux per os
Awarded to
- Arega Pharma BCE/KBO 0722.544.585
8 lots
- Amoxicilline 500 mg et 1000 mg, per os
- Amoxicilline + acide clavulanique 500 mg / 125 mg et 875 mg / 125 mg, per os
- Céfuroxime 500 mg, per os
- Clindamycine 300 mg, per os
- Ciprofloxacine 500 mg, per os
- Lévofloxacine 500 mg, per os
- Moxifloxacine 400 mg, per os
- Valaciclovir 500 mg, per os
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Accord-cadre ayant pour objet la fourniture de produits de contraste iodés et d'agents de diagnostic par résonance magnétique Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025 |
GUERBET Bayer GE HEALTHCARE Bracco Imaging Europe |
€42,237,307 |
| Accord-cadre ayant pour objet la fourniture de Ceftriaxone Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025 |
Fresenius Kabi | €960,210 |
| Accord-cadre ayant pour objet la fourniture de Palonosétron et d'Ondansétron Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025 |
Viatris Grindeks Kalceks Belgium ACCORD HEALTHCARE |
€761,230 |
| Accord-cadre ayant pour objet la fourniture de Bosutinib Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025 |
Pfizer | €3,061,220 |
| Accord-cadre ayant pour objet la fourniture de Fingolimod 0,5 mg Centrale de Négociation pour les Achats Hospitaliers · 3 January 2025 |
Viatris | – |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 1284-2025.